Filtered By:
Condition: Patent Foramen Ovale
Procedure: Cardiac Catheterization
This page shows you your search results in order of relevance. This is page number 2.
Order by Relevance | Date
Total 19 results found since Jan 2013.
Diagnostic Accuracy of Transesophageal Echocardiogram for the Detection of Patent Foramen Ovale: A Meta‐Analysis
ConclusionWhile TEE bubble study is considered to be the gold standard modality for diagnosing PFO, some PFOs may still be missed or misdiagnosed. It is important to understand the limitations of TEE and perhaps use other highly sensitive screening tests, such as transcranial doppler (TCD), in conjunction with TEE before scheduling a patient for transcatheter PFO closure.
Source: Echocardiography - December 23, 2013 Category: Cardiology Authors: M. K. Mojadidi, Nikolay Bogush, Jose Diego Caceres, Pavlos Msaouel, Jonathan Tobis Tags: Original Investigation Source Type: research
The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale
Conclusion: No difference was found in closure or complication rates between the Flatstent and the umbrella devices. With appropriate pre‐assessment of the PFO anatomy, the Flatstent works as a safe and effective method of treating the PFO from within the tunnel, especially in those with long tunnel PFOs. Longer follow up is needed to establish superiority. This article is protected by copyright. All rights reserved.
Source: Catheterization and Cardiovascular Interventions - November 20, 2014 Category: Cardiovascular & Thoracic Surgery Authors: Mert Aral, Michael Mullen Tags: Original Studies Source Type: research
PFO closure with only fluoroscopic guidance: 7 years real‐world single centre experience
ConclusionsIn our experience Fluoro‐G PFO closure was performed mainly in cases of simple anatomy, with similar results in terms of safety and efficacy compared to Echo‐G cases. Both fluoroscopy and total procedural times were lower in the Fluo‐G cases. © 2014 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 19, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Antonio Mangieri, Cosmo Godino, Matteo Montorfano, Francesco Arioli, Isabella Rosa, Silvia Ajello, Daniela Piraino, Alberto Monello, Anna Giulia Pavon, Giacomo Viani, Valeria Magni, Alberto Cappelletti, Alberto Margonato, Antonio Colombo Tags: Pediatric and Congenital Heart Disease Source Type: research
Clinical Use of the Amplatzer Device in the Management of Intracardiac Defects: A Single-Center Experience
Int J Angiol DOI: 10.1055/s-0038-1626718Device therapy is a viable alternative to open heart surgery in the management of intracardiac defects. The Amplatzer septal occluder (ASO) is one such device that has been adapted to close a wide variety of cardiac defects with few complications and a high success rate. This is a retrospective review of all the patients who received the ASO between 2012 and 2016 at the University of Kentucky. In total, 169 patients underwent percutaneous closure of a septal defect with Amplatzer during the timeframe studied, and of those, 91% received the device for an atrial septal defect or patent...
Source: International Journal of Angiology - January 30, 2018 Category: Cardiology Authors: Rao, Seema S. Scaff, Tyler L. Gurley, John Saha, Sibu Tags: Original Article Source Type: research
